DXC Technology (DXC) Q2 FY2027 earnings

Reported results

• Total revenue for Q2 FY27 was $3.03 billion, down 4.0% year-over-year and down 4.0% on an organic basis.
• Q2 FY27 EBIT was $66 million with an EBIT margin of 2.2%, while adjusted EBIT was $187 million with an adjusted EBIT margin of 6.2%.
• Q2 FY27 diluted earnings per share was $0.15, while Non-GAAP diluted earnings per share was $0.67, down 20.2% year-over-year.
• Cash generated from operations for Q2 FY27 was $217 million, down 46.9% year-over-year.
• Q2 FY27 free cash flow was $91 million, compared to $240 million in the second quarter of fiscal year 2026.

Guidance

• Full Fiscal Year 2027 total revenue is expected in the range of $11.91 billion and $11.98 billion, a decline of 5.5% to 5.0% year-over-year on an organic basis.
• Full Fiscal Year 2027 adjusted EBIT margin is expected to be in the range of 5.75% to 6.25%.
• Full Fiscal Year 2027 Non-GAAP diluted EPS is expected in the range of $2.25 to $2.50.
• Full Fiscal Year 2027 Free Cash Flow is expected to be ~$600 million.
• Third Quarter Fiscal 2027 total revenue is expected to be ~$2.98 billion, a decline of ~6.0% year-over-year on an organic basis.
• Third Quarter Fiscal 2027 adjusted EBIT margin is expected to be ~6.0%.
• Third Quarter Fiscal 2027 Non-GAAP Diluted EPS is expected to be ~$0.55.

Notes

DXC acknowledged ongoing discussions regarding a possible sale of its insurance business and updated assumptions defining expenses remaining in corporate post-allocation as part of a transition to a new segment structure.

Price and volatility reaction

The stock moved -1.6% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -20.9 vol points across the event (constant-maturity series — not the front-week crush).

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.